| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $2.20 | - | - |
| Q1'26 | $2.22 | $1.86 | -16.3% |
| Q3'25 | $1.94 | $2.04 | +5.3% |
| Q2'25 | $1.92 | $2.00 | +4.1% |
| Q1'25 | $1.40 | $1.53 | +9.0% |
| Q4'24 | $2.10 | $2.12 | +1.1% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.7B | - | - |
| Q1'26 | $1.7B | $1.6B | -2.6% |
| Q3'25 | - | $1.5B | - |
| Q2'25 | - | $1.5B | - |
| Q1'25 | - | $1.4B | - |
| Q4'24 | - | $1.4B | - |
Market Data
EFX is currently trading at $166.44, giving Equifax Inc. a market cap of 19.82B and a P/E ratio of 28.4. Today's range spans $164.79–$170.35, with shares opening at $169.13 and moving down $0.05 (0.0%) from the prior close. DailyIQ's technical score sits at 45/100 (HOLD) with a news sentiment reading of 77/100.
Over the past year EFX has traded between $150.75 and $271.84 - the current price is +10.4% off the 52-week low and -38.8% from the high. 32 analysts cover the stock with a Buy consensus and a mean 12-month target of $220.43 (range $173.00–$265.00), implying upside of +32.4%.
EFX sits at $166.44 (near 52-week lows) with a HOLD technical read (45/100) and bullish sentiment (77/100). The 19.82B market cap in Industrials (P/E: 28.4) makes this a name that institutional coverage maintains even through neutral phases - which means any catalyst shift will be quickly priced in. Annual range: $150.75–$271.84.
The 52-week range of $150.75–$271.84 for EFX provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $166.44 (near 52-week lows), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 45/100 and bullish news backdrop (77/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).